Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Genomics’ Role In Global Pathogen Surveillance, Diagnosis

    Nov 14, 2017, 10:05 AM by Michael Croft

    Bio-IT World | A recent Nature Reviews Genetics article explores the steps moving us toward a genomics-informed, real-time, global pathogen surveillance system, and the need for such progress.

    Full story
  • FDA Renews and Expands its Portfolio of Simcyp Simulator (PBPK) Licenses

    Nov 14, 2017, 09:44 AM by Michael Croft
    PRINCETON, NJ - Nov 14, 2017 - Certara®, the global leader in model-informed drug development and regulatory science, today announced that the US Food and Drug Administration (FDA) has greatly expanded its use of Certara’s PBPK Simcyp® Population-based Simulator and its Pediatric and Cardiac Safety Simulators
    Full story
  • Wiping Out Alzheimers Is Personal To Microsofts Bill Gates And Paul Allen

    Nov 13, 2017, 17:36 PM by Michael Croft
    Forbes | Bill Gates announced today that he will invest $50 million of his own money in the Dementia Discovery Fund. Gates has a different approach to funding Alzheimer's research than does Allen, his Microsoft co-founder, but the two are similar in their motives and beliefs about what it's going to take to conquer the disease.
    Full story
  • America Just Can’t Match China’s Exploding Supercomputing Power

    Nov 13, 2017, 13:10 PM by Michael Croft
    MIT Technology Review | What's up in emerging technology, including China's exploding supercomputing power.
    Full story
  • Transforming Information Into Knowledge In The Big Data Era

    Nov 13, 2017, 11:20 AM by Michael Croft

    Bio-IT World Contributed Commentary | Despite the overwhelming volume and complexity of scientific literature, and the myriad ways of accessing and managing it, the success of an entire research organization may depend on quick, efficient, cost-effective, and unfettered access to the information contained in reference publications. So, how do biomedical and drug discovery researchers effectively transform information into useful knowledge in the Big Data era?

    Full story
  • Bio-Optronics® and Complion Announce Integration to Unify Best-in-Class CTMS and eRegulatory Solutions for Clinical Research Organizations

    Nov 13, 2017, 09:39 AM by Michael Croft
    ROCHESTER, NY - Nov 13, 2017 - Bio-Optronics, the makers of the market leader Clinical Conductor Clinical Trial Management System (CTMS), and Complion, the powerful eRegulatory and document management platform for sites, have partnered to integrate their best-in-class solutions to deliver an industry-leading solution for research organizations
    Full story
  • Aircuity Announces its Airside Efficiency Platform to improve energy efficiency and indoor environmental quality

    Nov 9, 2017, 15:38 PM by Michael Croft
    NEWTON, MA, UNITED STATES - Nov 9, 2017 - Aircuity, maker of smart automated airside solutions, announces that its airside efficiency platform has been included in a major retrofit project by the National Research Council of Canada (NRC)
    Full story
  • Struggling GSK Recruits Cancer Drug Guru Hal Barron As Its New R&D Chief

    Nov 9, 2017, 13:05 PM by Michael Croft
    ENDPOINTS | GlaxoSmithKline has recruited Hal Barron, one of the world's top cancer drug investigators, to take the helm of its troubled pharma R&D group, offering a fresh sign that the pharma giant is jumping back in a big way into oncology.
    Full story
  • DuraTherm PLUS+ is an ISTA-validated shipping solution for temperature-sensitive payloads

    Nov 9, 2017, 11:04 AM by Michael Croft
    DENVER, CO, UNITED STATES - Nov 9, 2017 - Denver, CO - ACH Foam Technologies announces DuraTherm PLUS+™, an advanced cold chain shipping solution that assures payload temperatures remain between 2⁰ to 8⁰ Celsius for a 24-hour delivery window
    Full story
  • IDBS takes Bioprocess Execution Solution to the Cloud

    Nov 9, 2017, 10:17 AM by Michael Croft
    LONDON, UNITED KINGDOM - Nov 9, 2017 - Guildford UK, Boston, US, 9 November 2017 - Today, IDBS announces the release of its latest Bioprocess Execution (BPES) informatics solution
    Full story
  • DDN Partners With Hewlett Packard Enterprise To Deliver Unmatched HPC Storage Solutions

    Nov 9, 2017, 09:10 AM by Michael Croft

    Bio-IT World Brief | DDN has entered into a partnership with Hewlett Packard Enterprise (HPE) to integrate DDN’s parallel file system storage and flash storage cache technology with HPE’s HPC platforms. The focus of the partnership is to accelerate and simplify customers’ workflows in technical computing, artificial intelligence and machine learning environments.

    Full story
  • Build The Ebola Database In Africa

    Nov 8, 2017, 14:30 PM by Michael Croft
    Nature | To build trust, capacity and utility, put local researchers in charge of planned platform, says Brian Conton.
    Full story
  • SeraCare Announces Industry's First Comprehensive NGS Reference Material for Hematologic Malignancies

    Nov 8, 2017, 12:42 PM by Michael Croft
    MILFORD, MA, UNITED STATES - Nov 8, 2017 -  SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories, is expanding what is already the most comprehensive suite of clinical genomics development, validation, and QC tools with the launch of the SeraseqTM Myeloid DNA and Myeloid RNA fusion reference materials: the industry's first comprehensive reference standards to help ensure the sensitivity and robustness of next-generation sequencing (NGS) based assays focused on myeloid cancers
    Full story
  • Artificial Intelligence & Real World Data: The Next Steps In Your Big Data Journey

    Nov 8, 2017, 09:55 AM by Michael Croft

    Bio-IT World Contributed Commentary | KPMG’s CEO Survey found that some of the largest U.S. life sciences companies are sending mixed signals about their commitment to technology and trailing other industries in their plans to adopt cutting edge technologies.

    Full story
  • What Happens When You Put 500,000 Peoples DNA Online

    Nov 7, 2017, 16:32 PM by Michael Croft
    The Atlantic | Huge genetic databases are changing how scientists study disease.
    Full story
  • NIH Launches Data Commons Pilot With 9 Projects

    Nov 7, 2017, 13:00 PM by Michael Croft

    Bio-IT World Brief | Yesterday the National Institutes of Health announced twelve awards totaling $9 million in Fiscal Year 2017 to launch a National Institutes of Health Data Commons Pilot Phase. The NIH Data Commons will be implemented in a four-year pilot phase to explore the feasibility and best practices for making digital objects available through cloud-based collaborative platforms.

    Full story
  • Bioclinica Acquires MDDX Research & Informatics Combining Advanced Image Management Cloud Technology with Its Scientific and Medical Imaging Leadership

    Nov 7, 2017, 10:49 AM by Michael Croft
    AUDUBON, PA, UNITED STATES - Nov 6, 2017 - Bioclinica®, the world-leading provider of scientific-enabled Medical Imaging, eHealth, and patient-centric solutions supporting clinical research, today announces it has acquired Silicon Valley-based MDDX Research & Informatics, adding the industry’s most advanced cloud research image management and submission technologies to its extensive suite of eHealth solutions
    Full story
  • BioIVT to Present Advances in Immunohistochemistry at AAPS Annual Meeting

    Nov 7, 2017, 10:15 AM by Michael Croft
    WESTBURY, NY - Nov 7, 2017 - BioIVT, a leading provider of biospecimens and related services, today announced that it will be presenting and exhibiting at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting
    Full story
  • Creative Diagnostics Introduces Treponema Pallidum Antigens

    Nov 6, 2017, 23:26 PM by Michael Croft
    SHIRLEY, NY - Nov 8, 2017 - As a leading supplier of research products and custom services to global academic, pharmaceutical and biotech communities, Creative Diagnostics has introduced new  treponema pallidum antigens for the diagnosis of syphilis, including recombinant T
    Full story
  • Why Thomson Reuters' Introduction Of Enterprise Graph Analytics To Its Global Customers Is A Big Deal For Big Data

    Nov 6, 2017, 12:10 PM by Michael Croft
    International Business Times UK | Older technology hasn't been able to keep up with data volumes and demand for insights; Cambridge Semantics' Sean Martin explains why business should sit up and take notice.
    Full story
  • «
  • 301
  • 302
  • 303
  • 304
  • 305
  • 306 (current)
  • 307
  • 308
  • 309
  • 310
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy